Cargando…

Hitherto unseen survival in an ALK‐positive‐patient with advanced stage adult ganglioneuroblastoma treated with personalized medicine

Survival of stage 4 ganglioneuroblastoma (GNB) patients is poor; no reports exist of patients surviving up to 5 years (1, 2). We report the clinical and therapeutic course of a patient with stage 4 GNB surviving beyond expectations due to a multimodal treatment approach incorporating new technologie...

Descripción completa

Detalles Bibliográficos
Autores principales: Risum, Signe, Knigge, Ulrich, Langer, Seppo W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5715430/
https://www.ncbi.nlm.nih.gov/pubmed/29225862
http://dx.doi.org/10.1002/ccr3.1262